AKT1 and breast cancer: In this context, a reduction in protective autophagy flux by resveratrol was reported in association with impaired repair of double-strand breaks in BC cells, synergistically enhancing the effect of the PARP inhibitor talazoparib through dual inhibition of the PI3K/Akt signaling pathway [167].